FDA 483 - Tandem Diabetes Care, Inc. - December 23, 2014

An FDA inspection of Tandem Diabetes Care Inc, a medical device manufacturer in San Diego, CA, revealed multiple deficiencies in their quality system. Observations included inadequately approved process validation activities, poorly established process control procedures, and uncontrolled production processes. Additionally, the firm lacked adequate procedures for monitoring process parameters and schedules for equipment maintenance.